BAFFR | ApexOnco - Clinical Trials news and analysis

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Conferences Trial results

25 November 2025

An in vivo Car-T produced a 100% response rate – in three patients.

Trial results

12 August 2025

Conferences Trial results

10 December 2023

Recent Quick take